David-Alexandre C. Gros, MD, CEO at Eledon, discusses the milestone and the role of immunosuppression regimens for durable ...
Massachusetts General Hospital announced that Tim Andrews recovered well enough from the transplant to leave the hospital a ...
The transplant, part of a three-person compassionate use study, used a pig kidney with 69 gene edits provided by U ...
A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...
FDA approves the first clinical trials for pig kidney transplants in humans, testing genetically modified pig organs.
Doctors at Massachusetts General Hospital transplanted a pig kidney into a 66-year-old patient with end-stage kidney disease.
The recipient was Tim Andrews, a 66-year-old New Hampshire resident who had end-stage kidney disease and was on dialysis for ...
Massachusetts General Hospital has performed its second successful genetically edited pig kidney transplant into a patient, MGH reported on Friday. The “miracle” transplant is giving 66-year-old Tim ...